Cohen E, Harrington K, Le Tourneau C, et al. Pembrolizumab (pembro) vs standard of care (SOC) for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): Phase 3 KEYNOTE-040 trial. ESMO 2017 Congress; abstract LBA45_PR.
Craniale radiotherapie bij acute lymfatische leukemie leidt tot hersenschade later
apr 2017 | Leukemie, Radiotherapie